BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33834328)

  • 1. Correlation between SNPs of PIK3CA, ERBB2 3'UTR, and their interactions with environmental factors and the risk of epithelial ovarian cancer.
    Chen H; Zhai Z; Xie Q; Lai Y; Chen G
    J Assist Reprod Genet; 2021 Oct; 38(10):2631-2639. PubMed ID: 33834328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer.
    Zhang H; Zhou L
    Pathol Res Pract; 2019 Sep; 215(9):152520. PubMed ID: 31288947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.
    Schwich E; Rebmann V; Michita RT; Rohn H; Voncken JW; Horn PA; Kimmig R; Kasimir-Bauer S; Buderath P
    Sci Rep; 2019 Apr; 9(1):5407. PubMed ID: 30932005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for
    Al-Qahtani WS; Alduwish MA; Al-Olayan EM; Aljarba NH; Em AH; Albani FG; Domiaty DM; Al-Otaibi AM; Qattan SMA; Almurshedi AS; Elasbali AM; Ahmed HG; Almutlaq BA
    J Obstet Gynaecol; 2021 Oct; 41(7):1127-1133. PubMed ID: 33475035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
    Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
    BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
    Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
    Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
    Zhang HB; Zeng Y; Li TL; Wang G
    Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
    Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ;
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
    Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
    Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
    Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
    Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically predicted circulating protein biomarkers and ovarian cancer risk.
    Considine DPC; Jia G; Shu X; Schildkraut JM; Pharoah PDP; Zheng W; Kar SP;
    Gynecol Oncol; 2021 Feb; 160(2):506-513. PubMed ID: 33246661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ERBB2 gene polymorphisms rs2643194, rs2934971, and rs1058808 are associated with increased risk of gastric cancer.
    Vázquez-Ibarra KC; Bustos-Carpinteyro AR; García-Ruvalcaba A; Magaãa-Torres MT; Gutiérrez-Aguilar R; Marín-Contreras ME; Santiago-Luna E; Sánchez-López JY
    Braz J Med Biol Res; 2019; 52(5):e8379. PubMed ID: 31116314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of SOX4 gene 3'UTR polymorphisms on osteoporosis.
    Li G; Gu Z; He Y; Wang C; Duan J
    J Orthop Surg Res; 2021 May; 16(1):321. PubMed ID: 34006298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of WNT4 Gene with the Risk of Epithelial Ovarian Cancer: A Han Chinese Population-Based Association Study.
    Zhang J; Zhang P; Shen Y; Yang M; Zou H; Liu H
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):686-692. PubMed ID: 30457351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
    Quaye L; Song H; Ramus SJ; Gentry-Maharaj A; Høgdall E; DiCioccio RA; McGuire V; Wu AH; Van Den Berg DJ; Pike MC; Wozniak E; Doherty JA; Rossing MA; Ness RB; Moysich KB; Høgdall C; Blaakaer J; ; Easton DF; Ponder BA; Jacobs IJ; Menon U; Whittemore AS; Krüger-Kjaer S; Pearce CL; Pharoah PD; Gayther SA
    Br J Cancer; 2009 Mar; 100(6):993-1001. PubMed ID: 19240718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.
    Zammataro L; Lopez S; Bellone S; Pettinella F; Bonazzoli E; Perrone E; Zhao S; Menderes G; Altwerger G; Han C; Zeybek B; Bianchi A; Manzano A; Manara P; Cocco E; Buza N; Hui P; Wong S; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Angioli R; Raspagliesi F; Scambia G; Choi J; Dong W; Bilguvar K; Alexandrov LB; Silasi DA; Huang GS; Ratner E; Azodi M; Schwartz PE; Pirazzoli V; Stiegler AL; Boggon TJ; Lifton RP; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22730-22736. PubMed ID: 31624127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations.
    Ogasawara A; Hihara T; Shintani D; Yabuno A; Ikeda Y; Tai K; Fujiwara K; Watanabe K; Hasegawa K
    Cancer Res Treat; 2020 Oct; 52(4):1219-1228. PubMed ID: 32599986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.
    Toomey S; Eustace AJ; Fay J; Sheehan KM; Carr A; Milewska M; Madden SF; Teiserskiene A; Kay EW; O'Donovan N; Gallagher W; Grogan L; Breathnach O; Walshe J; Kelly C; Moulton B; Kennedy MJ; Gullo G; Hill AD; Power C; Duke D; Hambly N; Crown J; Hennessy BT
    Breast Cancer Res; 2017 Jul; 19(1):87. PubMed ID: 28750640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rs3802278 in 3'-UTR of
    Zeng F; Liu Y; Ouyang Q; Sun Z; Zhang K; Li X; Liu Y
    J Chemother; 2021 Dec; 33(8):564-569. PubMed ID: 34029511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms in FOXC2 gene and Epithelial ovarian Cancer susceptibility in Chinese population.
    Zhou Z; Ou X; Zou Q; Chu L; Quan X; Chen Y; Liu Y
    J Ovarian Res; 2020 Mar; 13(1):34. PubMed ID: 32222147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.